Belgian Trial Investigating the LifeStream Stent in Complex TASC C and D Iliac Lesions

General inclusion criteria: * Corresponding to the CE-mark indications/contra-indications and according to the current medical guidelines for minimally invasive peripheral interventions. * Patient presenting with a stenotic or occlusive lesion at the iliac arteries suitable for stenting (on indication for primary stenting, based on the discretion of the investigator) * Patient presenting a score from 2 to 4 following Rutherford classification * Patient is willing to comply with specified follow-up evaluations at the specified times for the duration of the study * Patient is \>18 years old * Patient (or their legal representative) understands the nature of the procedure and provides written informed consent, prior to enrolment in the study * Patient is eligible for treatment with the Lifestream Peripheral Stent Graft System (Bard) Angiographic inclusion criteria * The target lesion is either a modified TASC-II class C or D lesion with one of the listed specifications: * Type C lesions * Bilateral Common Iliac Artery occlusions * Bilateral External Iliac Artery stenoses 3-10 cm long not extending into the Common Femoral Artery * Type D lesions * Unilateral occlusions of both Common Iliac and External Iliac Artery * Diffuse disease involving the aorta bifurcation * Bilateral occlusions of External Iliac Artery * The target lesion has angiographic evidence of stenosis or restenosis post percutaneous transluminal angioplasty (PTA) \> 50% or occlusion …